OptimizeRx (OPRX) Stock Price, Quote, News & History | Benzinga

OptimizeRx Corp (OPRX) Stock Price, Quote, News & History

OPRXNASDAQ

Trade with Public

Trade with Public

$8.78

1.7424.72%

At close: Aug 12, 5:00 PM EST

$8.78

1.7424.72%

Pre-Market: 7:59 AM EST

Earnings: Q2 2026 Earnings were released on Wed Aug 12th, after the market close

Conference Call: The most recent conference call started at 4:30 PM, 2 days ago

Click to view the webcast

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$8.78

Volume / Avg.

565.00 / 410.85K

Day Range

- - -

52 Wk Range

4.54 - 22.25

Market Cap

$162.39M

P/E Ratio

35.12

Dividend Yield

-

Exchange

NASDAQ

RSI

79

Short Interest

7.79%

Days to Cover

6.34

Recent OptimizeRx Corporation News

OptimizeRx Warns Of Volatility From 'Most Favored Nation' Pricing Uncertainty

OptimizeRx CEO warns of increased market volatility and uncertainty around MFN pricing. Lower 2026 forecasts due to cautious spending.

Vandana Singh

Why Expedia Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

OptimizeRx Stock Rallies 22% After-Hours Thanks To Q2 Earnings Push

OptimizeRx's stock jumped 22.66% after hours following strong Q2 earnings that beat expectations and lifted the share price from $12.84 to $15.75.

Mohd Haider

US Stocks Likely To Open Lower After A Strong Rally: 'Lows Are Likely In And Better Times Are Coming,' Says Expert

U.S. stock futures fell on Tuesday after a stellar rally on Monday. Futures of major benchmark indices were trading lower in premarket.

Rishabh Mishra

OptimizeRx Clocks Double-Digit Revenue Growth In Q4, Forecasts Sales Of At Least $100 Million

OptimizeRx reports sales of $32.32M in Q4, beating consensus, with adjusted EPS of $0.30. Full-year revenue increased 29% and EBITDA grew 53%.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

14.38M

Investing Cash Flow (TTM)

131.00K

Financing Cash Flow (TTM)

-10.92M

Free Cash Flow (TTM)

14.45M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

3.60M

Analyst Trends and Forecast

4

1

Mar

3

1

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.1

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$160.74M

PE Ratio (TTM)

35.12

PE Ratio (FWD)

9.54

PEG Ratio (TTM)

-

PS Ratio (TTM)

1.70

PB Ratio (TTM)

1.26

Earnings Yield % (TTM)

2.85%

Earnings Yield % (FWD)

10.48%

EV / EBITDA (TTM)

10.23

Price / EBITDA (TTM)

10.69

Price / Free Cash Flow (TTM)

9.08

Book Value / Share

$6.96

Company Debt

Total Debt

$23.34M

LT Debt

$21.34M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$10.19M

Total Cash

$20.17M

Debt to Equity

0.15

Issuance of Debt (TTM)

-$10.19M

Repayment of Debt (TTM)

-$10.19M

Key Statistics

Open

-

Close

$8.78

Volume / Avg.

565.00 / 410.85K

Day Range

- - -

52 Wk Range

4.54 - 22.25

Market Cap

$162.39M

P/E Ratio

35.12

Dividend Yield

-

Exchange

NASDAQ

RSI

79

Short Interest

7.79%

Days to Cover

6.34

About

Sector

Health Care

Industry

Health Care Technology

OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a propr...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy OptimizeRx (OPRX) stock?

A

You can purchase shares of OptimizeRx (NASDAQ:OPRX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are OptimizeRx (OPRX) competitors?

A

Other companies in OptimizeRx’s space includes: Veeva Systems Inc (NYSE:VEEV), Waystar Holding Corp (NASDAQ:WAY), Doximity Inc (NYSE:DOCS), HeartFlow Inc (NASDAQ:HTFL) and Schrodinger Inc (NASDAQ:SDGR).

Q

What is the forecast, or price target, for OptimizeRx (OPRX) stock?

A

OptimizeRx has a consensus price target of $13.36.

Q

What is the current price for OptimizeRx (OPRX)?

A

The stock price for OptimizeRx (NASDAQ: OPRX) is $8.78 last updated August 14, 2026 at 5:23 AM EDT.

Q

Does OptimizeRx (OPRX) pay a dividend?

A

There are no upcoming dividends for OptimizeRx.

Q

When is OptimizeRx (NASDAQ:OPRX) reporting earnings?

A

OptimizeRx does not have any upcoming earnings scheduled.

Q

Is OptimizeRx (OPRX) going to split?

A

There is no upcoming split for OptimizeRx.

Q

What sector and industry does OptimizeRx (OPRX) operate in?

A

OptimizeRx is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.